KCT0000795已完成未知
Bioequivalence of torasemide 5 mg in Korean subjects
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 55(Year)（—）
- 性别
- All
入选标准
- •1. Subjects between the ages of 19 and 55 years
- •2. No History of congenital or chronic disease
- •3. No clinically relevant abnormalities identified by laboratory test, including hematology, blood chemistry, and urinalysis
- •4. Female subject known to be negative for pregnant test
排除标准
- •1. Use of any drugs (Barbitals, alcohol) known to significantly induce or inhibit drug-metabolizing enzymes within 1 month prior to dosing
- •2. Received any drugs within 10 days before the study
- •3. Inappropriate subject for entry into this study in the judgement of the investigator
研究者
相似试验
已完成
不适用
Bioequivalence of torasemide 10 mg in Korean subjectsKCT0000794Chonnam National University28
已完成
不适用
Bioequivalence of Sam Chun Dang torasemide 5 mg in Korean subjectsKCT0000799Chonnam National University28
已完成
不适用
Bioequivalence of Sam Chun Dang torasemide 20 mg in Korean subjectsKCT0000798Chonnam National University28
已完成
不适用
Bioequivalency Study of Torsemide Tablets Under Fed ConditionsEdemaNCT00602615Roxane Laboratories28
已完成
不适用
Bioequivalency Study of Torsemide Tablets Under Fasting ConditionsEdemaNCT00602303Roxane Laboratories28